Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMC2012 bone marrow-derived mononuclear cell therapy for proximal humeral fractures
2015-001820-51Phase 2Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Oct 2015
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bone marrow mononuclear cells in proximal humerus fracture (PHF) (2 arms), sponsored by Goethe University Frankfurt. Primary endpoint: Osseous healing of fracture at 12 weeks. Started Oct 2015; status: completed.
02
Drugs
bone marrow mononuclear cells
03
Conditions
proximal humerus fracture (PHF)
Beyond the preview
Go deeper on 2015-001820-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001820-51.